Biochemical Functions of Coenzyme Q10

Coenzyme Q is well defined as a crucial component of the oxidative phosphorylation process in mitochondria which converts the energy in carbohydrates and fatty acids into ATP to drive cellular machinery and synthesis. New roles for coenzyme Q in other cellular functions are only becoming recognized. The new aspects have developed from the recognition that coenzyme Q can undergo oxidation/reduction reactions in other cell membranes such as lysosomes, Golgi or plasma membranes. In mitochondria and lysosomes, coenzyme Q undergoes reduction/oxidation cycles during which it transfers protons across the membrane to form a proton gradient. The presence of high concentrations of quinol in all membranes provides a basis for antioxidant action either by direct reaction with radicals or by regeneration of tocopherol and ascorbate. Evidence for a function in redox control of cell signaling and gene expression is developing from studies on coenzyme Q stimulation of cell growth, inhibition of apoptosis, control of thiol groups, formation of hydrogen peroxide and control of membrane channels. Deficiency of coenzyme Q has been described based on failure of biosynthesis caused by gene mutation, inhibition of biosynthesis by HMG coA reductase inhibitors (statins) or for unknown reasons in ageing and cancer. Correction of deficiency requires supplementation with higher levels of coenzyme Q than are available in the diet.

[1]  R. S. Sohal,et al.  Mitochondrial coenzyme Q content and aging , 1999, BioFactors.

[2]  F. Rosenfeldt,et al.  Coenzyme Q10 improves the tolerance of the senescent myocardium to aerobic and ischemic stress: Studies in rats and in human atrial tissue , 1999, BioFactors.

[3]  U. Brandt.  Proton translocation in the respiratory chain involving ubiquinone — a hypothetical semiquinone switch mechanism for complex I , 1999, BioFactors.

[4]  J. Bergemann,et al.  Coenzyme Q10, a cutaneous antioxidant and energizer , 1999, BioFactors.

[5]  E. Elstner,et al.  Coenzyme Q10, vitamin E, and dihydrothioctic acid cooperatively prevent diene conjugation in isolated low-density lipoprotein. , 2000, Antioxidants & redox signaling.

[6]  W. Cramer,et al.  Energy transduction function of the quinone reactions in cytochrome bc complexes , 1999, BioFactors.

[7]  M. Beal,et al.  Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases , 1999, BioFactors.

[8]  A. Osterborg,et al.  Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. , 1997, Biochemical and biophysical research communications.

[9]  Copenhagen,et al.  CoQ10: Could it have a role in cancer management? , 1999, BioFactors.

[10]  R. de Cabo,et al.  NADH and NADPH-dependent reduction of coenzyme Q at the plasma membrane. , 2000, Antioxidants & redox signaling.

[11]  Y. Liu,et al.  Conditions allowing redox-cycling ubisemiquinone in mitochondria to establish a direct redox couple with molecular oxygen. , 1996, Free radical biology & medicine.

[12]  P. Navas,et al.  Plasma membrane redox system in the control of stress-induced apoptosis. , 2000, Antioxidants & redox signaling.

[13]  M. Mccarty,et al.  Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics? , 1999, Medical hypotheses.

[14]  V. Mildažienė,et al.  Dependence of H2O2 Formation by Rat Heart Mitochondria on Substrate Availability and Donor Age , 1997, Journal of bioenergetics and biomembranes.

[15]  H. Hansen,et al.  Coenzyme Q10 treatment in serious heart failure , 1999, BioFactors.

[16]  H. Asard,et al.  Plasma Membrane Redox Systems and their Role in Biological Stress and Disease , 1998, Springer Netherlands.

[17]  A. Jesaitis,et al.  The cytochrome b-558 molecules involved in the fibroblast and polymorphonuclear leucocyte superoxide-generating NADPH oxidase systems are structurally and genetically distinct. , 1993, The Biochemical journal.

[18]  F. L. Crane,et al.  Antioxidative Role of Ubiquinone in the Animal Plasma Membrane , 1998 .

[19]  F. L. Crane,et al.  Genetic Evidence for Coenzyme Q Requirement in Plasma Membrane Electron Transport , 1998, Journal of bioenergetics and biomembranes.

[20]  R. de Cabo,et al.  Protective role of ubiquinone in vitamin E and selenium‐deficient plasma membranes , 1999, BioFactors.

[21]  D. M. Morré,et al.  The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. , 1999, Biochimica et biophysica acta.

[22]  F. L. Crane,et al.  alpha-Adrenergic stimulation of trans-sarcolemma electron efflux in perfused rat heart. Possible regulation of Ca2+-channels by a sarcolemma redox system. , 1985, Biochimica et biophysica acta.

[23]  T. Forsén,et al.  The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus , 1999, BioFactors.

[24]  P. Langsjoen,et al.  Overview of the use of CoQ10 in cardiovascular disease , 1999, BioFactors.

[25]  P. Quinn,et al.  Expansion of antioxidant function of vitamin E by coenzyme Q , 1999, BioFactors.

[26]  F. L. Crane,et al.  Requirement for coenzyme Q in plasma membrane electron transport. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Munnich,et al.  Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency , 2000, The Lancet.

[28]  A. Bysted,et al.  Coenzyme Q10 in the diet--daily intake and relative bioavailability. , 1997, Molecular aspects of medicine.

[29]  G. Dallner,et al.  Induction of endogenous coenzyme Q biosynthesis by administration of peroxisomal inducers , 1999, BioFactors.

[30]  H. Mclennan,et al.  The Contribution of Mitochondrial Respiratory Complexes to the Production of Reactive Oxygen Species , 2000, Journal of bioenergetics and biomembranes.

[31]  F. L. Crane,et al.  The natural occurrence of coenzyme Q and related compounds. , 1959, The Journal of biological chemistry.

[32]  M. Morad,et al.  Redox regulation of cardiac muscle calcium signaling. , 2000, Antioxidants & redox signaling.

[33]  M. Berridge,et al.  High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases. , 2000, Antioxidants & redox signaling.

[34]  P. Navas,et al.  Involvement of Plasma Membrane Redox Systems in Growth Control of Animal and Plant Cells , 1998 .

[35]  Y. Yamamoto,et al.  Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress. , 1997, Molecular aspects of medicine.

[36]  G. Dallner,et al.  Ubiquinone biosynthesis by the microsomal fraction from rat liver. , 1987, Biochimica et biophysica acta.

[37]  Y. Suh,et al.  Cell transformation by the superoxide-generating oxidase Mox1 , 1999, Nature.

[38]  G. López-Lluch,et al.  Coenzyme Q protects cells against serum withdrawal-induced apoptosis by inhibition of ceramide release and caspase-3 activation. , 2000, Antioxidants & redox signaling.

[39]  F. L. Crane,et al.  Chapter 6 Oxidase control of plasma membrane proton transport , 1996 .

[40]  A. Smith,et al.  Links between cell-surface events involving redox-active copper and gene regulation in the hemopexin heme transport system. , 2000, Antioxidants & redox signaling.

[41]  I. Pessah,et al.  Functional role of hyperreactive sulfhydryl moieties within the ryanodine receptor complex. , 2000, Antioxidants & redox signaling.

[42]  G. López-Lluch,et al.  Role of plasma membrane coenzyme Q on the regulation of apoptosis , 1999, BioFactors.

[43]  J. Stamler,et al.  The Skeletal Muscle Calcium Release Channel Coupled O2 Sensor and NO Signaling Functions , 2000, Cell.

[44]  T. Kishi,et al.  Characterization of NADPH-dependent ubiquinone reductase activity in rat liver cytosol: effect of various factors on ubiquinone-reducing activity and discrimination from other quinone reductases. , 1996, Journal of biochemistry.

[45]  F. L. Crane,et al.  NADH diferric transferrin reductase in liver plasma membrane. , 1987, The Journal of biological chemistry.

[46]  L. Packer,et al.  Handbook of Antioxidants , 2001 .

[47]  Christian Kaltschmidt,et al.  Activation of NF-κB by Reactive Oxygen Intermediates in the Nervous System , 1999 .

[48]  A. Frankel,et al.  Yeast and Rat Coq3 and Escherichia coli UbiG Polypeptides Catalyze Both O-Methyltransferase Steps in Coenzyme Q Biosynthesis* , 1999, The Journal of Biological Chemistry.

[49]  M. Battino,et al.  Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. , 1994, Molecular aspects of medicine.

[50]  M. Battino,et al.  Coenzyme Q homologs and vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the ageing rat. , 1997, Molecular aspects of medicine.

[51]  J. Wrigglesworth,et al.  Tissue concentrations of coenzyme Q10 in the rat following its oral and intraperitoneal administration. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[52]  F. L. Crane,et al.  Modification of transmembrane electron transport activity in plasma membranes of simian virus 40 transformed pineal cells. , 1986, Biochimica et biophysica acta.

[53]  A. Munnich,et al.  Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron‐induced injury in vitro , 1999, BioFactors.

[54]  E. Agner,et al.  Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. , 1997, Molecular aspects of medicine.

[55]  R. Willis,et al.  Clinical implications of the correlation between coenzyme Q10 and vitamin B6 status , 1999, BioFactors.

[56]  G. Rossi,et al.  [COENZYME Q]. , 1964, Pathologica.

[57]  F. L. Crane,et al.  Electron and proton transport across the plasma membrane , 1991, Journal of bioenergetics and biomembranes.

[58]  R. Dean,et al.  Direct Copper Reduction by Macrophages , 1997, The Journal of Biological Chemistry.

[59]  R. Stocker,et al.  A role for reduced coenzyme Q in atherosclerosis? , 1999, BioFactors.

[60]  F. L. Crane,et al.  Generation of hydrogen peroxide on oxidation of NADH by hepatic plasma membranes , 1981, Journal of bioenergetics and biomembranes.

[61]  L. Gille,et al.  The existence of a lysosomal redox chain and the role of ubiquinone. , 2000, Archives of biochemistry and biophysics.

[62]  M. L. Genova,et al.  Localization and mobility of coenzyme Q in lipid bilayers and membranes , 1999, BioFactors.

[63]  T. Nakamura,et al.  Metabolism of coenzyme Q10: Biliary and urinary excretion study in guinea pigs , 1999, BioFactors.

[64]  C. Clarke,et al.  Sensitivity to treatment with polyunsaturated fatty acids is a general characteristic of the ubiquinone-deficient yeast coq mutants. , 1997, Molecular aspects of medicine.

[65]  F. L. Crane,et al.  Decrease of NADH in HeLa cells in the presence of transferrin or ferricyanide. , 1986, Biochemical and biophysical research communications.